LYEL Lyell Immunopharma, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$9,26
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$9,22mínimo 52 semanas
$40,11máximo 52 semanas
Capitalización Bursátil (MRQ)
$217M
P/E (TTM)
-0.6
BPA (TTM)
$-16.01
Ingresos (TTM)
$27.0K
tus insignias
Rango 52S
$9–$40
Calificación del Analista
BUY
Precio Objetivo
$38
P/E
-0.6
ROE
-93.3%
Margen de Beneficio Neto
-920285.2%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
LYEL Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$9.26
Capitalización Bursátil (MRQ)
$217M
P/E (TTM)
-0.6
BPA (TTM)
$-16.01
Ingresos (TTM)
$27.0K
ROE (TTM)
-93.3%
Rango 52S
$9–$40
LYEL Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 2 de junio de 2025 | 1-for-20 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$36.0K2019-12-31 → 2025-12-31
BPA$-16.062019-12-31 → 2025-12-31
Flujo de caja libre$-151M2021-12-31 → 2025-12-31
Margen neto-920285.2%2021-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | LYEL | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -0.6promedio 5A ≈-36.5 | ≈-36.5 | · | · | |
| P/S (TTM) | 8024.3promedio 5A ≈31914.9 | ≈31914.9 | 14.6 | Sobrevalorado | |
| P/C (MRQ) | 0.9promedio 5A ≈17.7 | ≈17.7 | 2.9 | Infravalorado | |
| Precio / FCF (TTM) | -1.6promedio 5A ≈-74.4 | ≈-74.4 | · | · | |
| Precio / Flujo de Caja (TTM) | -1.6promedio 5A ≈-97.5 | ≈-97.5 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 0.9promedio 5A ≈17.7 | ≈17.7 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | LYEL | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -949981.5%promedio 5A ≈-305742.2% | ≈-305742.2% | -752.1% | Débil | |
| Margen EBITDA (TTM) | -914733.3%promedio 5A ≈-289750.0% | ≈-289750.0% | -752.1% | Débil | |
| Margen de Beneficio Neto (TTM) | -920285.2%promedio 5A ≈-301538.5% | ≈-301538.5% | -1884.8% | Débil | |
| ROA (TTM) | -71.3%promedio 5A ≈-38.3% | ≈-38.3% | -27.3% | Débil | |
| ROE (TTM) | -93.3%promedio 5A ≈-51.7% | ≈-51.7% | -31.2% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | LYEL | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 5.4promedio 5A ≈11.9 | ≈11.9 | 8.4 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 5.0promedio 5A ≈11.6 | ≈11.6 | 5.3 | En línea |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | LYEL | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -41.0%promedio 5A ≈107.7% | ≈107.7% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | -92.5%promedio 5A ≈-83.0% | ≈-83.0% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | -65.8% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | LYEL | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.0 | ≈0.0 | 0.3 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$223.60 | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-20.5%
Próximo informe
Nov 09, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 10, 2026 | $-1.92 | $-2.06 | 6.7% |
| 31 de marzo de 2026 | May 11, 2026 | $-1.10 | $-2.41 | 54.4% |
| 31 de diciembre de 2025 | $-7.50 | $-2.28 | -229.5% | |
| 30 de septiembre de 2025 | $-2.13 | $-2.70 | 21.0% | |
| 30 de junio de 2025 | $-2.89 | $-3.65 | 20.9% | |
| 31 de marzo de 2025 | $-3.54 | $-3.67 | 3.6% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $36.0K | $61.0K | $130.0K | $85M | $11M | $8M | |
| R&D Expense | · | · | $183M | $159M | $139M | $182M | |
| SG&A Expense | $45M | $52M | $67M | $117M | $89M | $47M | |
| Operating Expenses | $269M | $359M | $247M | $272M | $225M | $220M | |
| Operating Income | $-269M | $-359M | $-247M | $-187M | $-215M | $-212M | |
| Other Non-op | $-18M | $5M | $2M | $2M | $-161.0K | $2M | |
| Income Tax | $0 | · | · | · | · | · | |
| Net Income | $-274M | $-343M | $-235M | $-183M | $-250M | $-204M | |
| EPS (Basic) | $-16.06 | $-26.23 | $-18.70 | $-0.74 | $-1.84 | $-15.69 | |
| EPS (Diluted) | $-16.06 | $-26.23 | $-18.70 | $-0.74 | $-1.84 | $-15.69 | |
| Shares (Basic) | 17,093,000 | 13,074,000 | 12,549,000 | 247,080,000 | 135,918,000 | 13,258,000 | |
| Shares (Diluted) | 17,093,000 | 13,074,000 | 12,549,000 | 247,080,000 | 135,918,000 | 13,258,000 | |
| EBITDA | $-258M | $-339M | $-227M | $-169M | $-201M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $60M | $106M | $146M | $124M | $294M | $140M | |
| Short-term Investments | $187M | $265M | $401M | $517M | $321M | $472M | |
| Prepaid Expense | $14M | $9M | $8M | $11M | $11M | $5M | |
| Current Assets | $261M | $380M | $555M | $651M | $626M | $618M | |
| PP&E (Net) | $35M | $48M | $103M | $123M | $120M | $77M | |
| PP&E (Gross) | $109M | $119M | $154M | $155M | $135M | $82M | |
| Accum. Depreciation | $74M | $71M | $52M | $32M | $15M | $5M | |
| Other Non-current Assets | $5M | $5M | $4M | $5M | $3M | $3M | |
| Total Assets | $340M | $491M | $750M | $938M | $1.13B | $908M | |
| Accounts Payable | $3M | $5M | $5M | $4M | $3M | $9M | |
| Current Liabilities | $49M | $54M | $35M | $37M | $47M | $49M | |
| Capital Leases | $42M | $51M | $57M | $63M | $67M | $51M | |
| Other Non-current Liabilities | $517.0K | $3M | $4M | $4M | $5M | $532.0K | |
| Total Liabilities | $92M | $108M | $95M | $104M | $198M | $190M | |
| Common Stock | $2.0K | $1.0K | $25.0K | $25.0K | $24.0K | $2.0K | |
| Paid-in Capital | $1.87B | $1.73B | $1.66B | $1.61B | $1.52B | $41M | |
| Retained Earnings | $-1.62B | $-1.35B | $-1.00B | $-767M | $-584M | $-334M | |
| AOCI | $242.0K | $291.0K | $-94.0K | $-8M | $-2M | $256.0K | |
| Stockholders' Equity | $248M | $383M | $655M | $833M | $930M | $-293M | |
| Liabilities + Equity | $340M | $491M | $750M | $938M | $1.13B | $908M | |
| Shares Outstanding | 21,251,000 | 14,744,000 | 12,698,000 | 12,479,000 | 242,738,000 | 15,570,000 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $12M | $20M | $20M | $18M | $14M | $4M | |
| Stock-based Comp | $42M | $33M | $47M | $82M | $62M | $33M | |
| Restructuring | · | · | $6M | · | · | · | |
| Other Non-cash | $71M | $128M | $4M | $-86M | $48M | · | |
| Operating Cash Flow | $-150M | $-162M | $-164M | $-170M | $-126M | $-161M | |
| CapEx | $780.0K | $464.0K | $3M | $24M | $66M | $51M | |
| Investing Cash Flow | $54M | $122M | $184M | $-12M | $-122M | $-274M | |
| Stock Issued | $50M | $0 | $0 | · | · | · | |
| Stock Repurchased | · | · | · | $0 | $0 | $12M | |
| Net Stock Activity | $50M | · | · | $0 | $0 | · | |
| Financing Cash Flow | $50M | $1M | $2M | $11M | $401M | $477M | |
| Net Change in Cash | $-46M | $-39M | $22M | $-170M | $153M | $42M | |
| Free Cash Flow | $-151M | $-163M | $-166M | $-194M | $-192M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -748344.4% | -588123.0% | -190006.1% | -220.9% | -2016.7% | · | |
| Net Margin | -762355.6% | -562285.2% | -180486.1% | -216.2% | -2349.5% | · | |
| EBITDA Margin | -716291.7% | -555941.0% | -174429.2% | -199.6% | -1888.8% | · | |
| ROA | -66.1% | -55.3% | -27.8% | -17.7% | -24.6% | · | |
| ROE | -100.3% | -75.1% | -34.7% | -22.1% | -26.1% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.3 | 7.1 | 16.1 | 17.6 | 13.4 | · | |
| Quick Ratio | 5.0 | 6.9 | 15.8 | 17.3 | 13.2 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $11.68 | $1.30 | $2.58 | $3.34 | $3.83 | · | |
| Revenue / Share | $0.00 | $0.00 | $0.00 | $0.34 | $78.36 | · | |
| Cash Flow / Share | $-8.78 | $-0.62 | $-0.65 | $-0.69 | $-928.86 | · | |
| Cash / Share | $2.83 | $0.36 | $0.57 | $0.50 | $1.21 | · | |
| EPS (TTM) | $-16.06 | $-26.23 | $-18.70 | $-0.74 | $-1.84 | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -41.0% | -53.1% | -99.9% | 695.1% | 37.3% | · | |
| Revenue CAGR 3Y | -92.5% | -82.1% | -74.4% | · | · | · | |
| Revenue CAGR 5Y | -65.8% | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $36.0K | $61.0K | $130.0K | $85M | $11M | · | |
| Net Income TTM | $-274M | $-343M | $-235M | $-183M | $-250M | · | |
| Market Cap | $654M | $3.77B | $9.85B | $17.32B | $37.58B | · | |
| P/E | -1.9 | -0.5 | -2.1 | -93.8 | -84.1 | · | |
| P/S | 18169.6 | 61875.6 | 75796.7 | 204.5 | 3528.2 | · | |
| P/B | 2.6 | 9.9 | 15.0 | 20.8 | 40.4 | · | |
| P / Tangible Book | 2.6 | 9.9 | 15.0 | 20.8 | 40.4 | · | |
| P / Cash Flow | -4.4 | -23.2 | -60.2 | -102.1 | -297.6 | · | |
| P / FCF | -4.3 | -23.2 | -59.2 | -89.4 | -196.0 | · | |
| Earnings Yield | -52.2% | -204.9% | -48.2% | -1.1% | -1.2% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.0K | $2.0K | $6.0K | $15.0K | $8.0K | $7.0K | $11.0K | $34.0K | $13.0K | $3.0K | $25.0K | $27.0K | $65.0K | $3.0K | $36M | $553.0K | |
| R&D Expense | $40M | $37M | · | $28M | $35M | $43M | · | $40M | $40M | $43M | $44M | $47M | $45M | $42M | $44M | $36M | |
| SG&A Expense | $10M | $10M | $11M | $11M | $10M | $14M | $15M | $12M | $12M | $13M | $16M | $19M | $19M | $26M | $30M | $34M | |
| Operating Expenses | $47M | $44M | $128M | $37M | $47M | $57M | $201M | $51M | $52M | $56M | $59M | $66M | $63M | $66M | $73M | $69M | |
| Operating Income | $-47M | $-44M | $-128M | $-37M | $-47M | $-57M | $-201M | $-51M | $-52M | $-56M | $-59M | $-66M | $-63M | $-66M | $-37M | $-69M | |
| Other Non-op | $398.0K | $18M | $-16M | $-5M | $1M | $1M | $4M | $-43.0K | $-645.0K | $1M | $2M | $-326.0K | $1M | $-1M | $-14.0K | $35.0K | |
| Net Income | $-45M | $-24M | $-141M | $-39M | $-43M | $-52M | $-192M | $-45M | $-46M | $-61M | $-51M | $-64M | $-67M | $-70M | $-36M | $-68M | |
| EPS (Basic) | $-1.92 | $-1.10 | $-10.86 | $-2.13 | $-2.89 | $-3.54 | $-18.92 | $-3.48 | $-3.59 | $-0.24 | $-0.20 | $-0.26 | $-0.27 | $-0.28 | $-0.15 | $-0.28 | |
| EPS (Diluted) | $-1.92 | $-1.10 | $-10.86 | $-2.13 | $-2.89 | $-3.54 | $-18.92 | $-3.48 | $-3.59 | $-0.24 | $-0.20 | $-0.26 | $-0.27 | $-0.28 | $-0.15 | $-0.28 | |
| Shares (Basic) | 23,364,000 | 21,876,000 | · | 18,268,000 | 14,793,000 | 14,755,000 | · | 12,815,000 | 12,770,000 | 254,252,000 | 251,318,000 | 250,204,000 | 249,591,000 | 248,320,000 | 246,312,000 | 244,178,000 | |
| Shares (Diluted) | 23,364,000 | 21,876,000 | · | 18,268,000 | 14,793,000 | 14,755,000 | · | 12,815,000 | 12,770,000 | 254,252,000 | 251,318,000 | 250,204,000 | 249,591,000 | 248,320,000 | 246,312,000 | 244,178,000 | |
| EBITDA | $-47M | $-42M | · | $-37M | $-47M | $-54M | · | $-51M | · | $-51M | $-59M | $-66M | $-58M | $-66M | $-37M | $-64M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $73M | $91M | $60M | $124M | $99M | $120M | $106M | $100M | $133M | $126M | $286M | $224M | $109M | $116M | $206M | $223M | |
| Short-term Investments | $131M | $163M | $187M | $196M | $178M | $181M | $265M | $340M | $358M | $401M | $289M | $371M | $503M | $532M | $450M | $391M | |
| Prepaid Expense | $9M | $13M | $14M | $9M | $5M | $8M | $9M | $9M | $9M | $8M | $11M | $11M | $12M | $12M | $11M | $12M | |
| Current Assets | $214M | $267M | $261M | $328M | $282M | $309M | $380M | $450M | $500M | $534M | $587M | $606M | $624M | $660M | $667M | $626M | |
| PP&E (Net) | $31M | $33M | $35M | $37M | $39M | $44M | $48M | $88M | $93M | $98M | $108M | $114M | $119M | $126M | $128M | $126M | |
| PP&E (Gross) | · | · | $109M | · | · | · | $119M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $74M | · | · | · | $71M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $6M | $5M | $5M | $3M | $3M | $3M | $5M | $5M | $4M | $4M | $4M | $5M | $5M | $3M | $4M | $4M | |
| Total Assets | $311M | $351M | $340M | $408M | $385M | $430M | $491M | $619M | $654M | $694M | $795M | $835M | $880M | $977M | $1.02B | $1.07B | |
| Accounts Payable | $4M | $5M | $3M | $3M | $3M | $4M | $5M | $4M | $4M | $5M | $4M | $6M | $6M | $5M | $4M | $7M | |
| Current Liabilities | $40M | $37M | $49M | $32M | $37M | $41M | $54M | $34M | $31M | $32M | $35M | $34M | $31M | $51M | $50M | $41M | |
| Capital Leases | $37M | $39M | $42M | $44M | $47M | $49M | $51M | $51M | $53M | $55M | $59M | $60M | $62M | $65M | $66M | $67M | |
| Other Non-current Liabilities | $537.0K | $527.0K | $517.0K | $3M | $3M | $3M | $3M | $4M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Total Liabilities | $77M | $77M | $92M | $79M | $87M | $93M | $108M | $89M | $88M | $91M | $97M | $98M | $97M | $157M | $154M | $191M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $30.0K | $1.0K | $26.0K | $26.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | |
| Paid-in Capital | $1.92B | $1.92B | $1.87B | $1.81B | $1.74B | $1.73B | $1.73B | $1.68B | $1.68B | $1.67B | $1.65B | $1.64B | $1.62B | $1.59B | $1.57B | $1.54B | |
| Retained Earnings | $-1.69B | $-1.64B | $-1.62B | $-1.48B | $-1.44B | $-1.40B | $-1.35B | $-1.15B | $-1.11B | $-1.06B | $-949M | $-898M | $-834M | $-759M | $-689M | $-653M | |
| AOCI | $-158.0K | $-9.0K | $242.0K | $201.0K | $57.0K | $158.0K | $291.0K | $760.0K | $-397.0K | $-404.0K | $-1M | $-2M | $-4M | $-10M | $-8M | $-7M | |
| Stockholders' Equity | $234M | $274M | $248M | $329M | $299M | $337M | $383M | $531M | $567M | $603M | $698M | $737M | $784M | $820M | $868M | $881M | |
| Liabilities + Equity | $311M | $351M | $340M | $408M | $385M | $430M | $491M | $619M | $654M | $694M | $795M | $835M | $880M | $977M | $1.02B | $1.07B | |
| Shares Outstanding | 23,397,000 | 23,328,000 | 21,251,000 | 19,294,000 | 14,831,000 | 295,284,000 | 14,744,000 | 256,564,000 | 255,948,000 | 254,927,000 | 251,869,000 | 251,027,000 | 249,609,000 | 249,240,000 | 247,110,000 | 245,423,000 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | |
| Stock-based Comp | $5M | $4M | $26M | $5M | $5M | $6M | $8M | $8M | $8M | $9M | $11M | $14M | $14M | $19M | $22M | $22M | |
| Other Non-cash | · | $-21M | · | · | · | $-12M | · | · | · | $4M | · | · | $2M | · | · | $-6M | |
| Operating Cash Flow | $-34M | $-39M | $-32M | $-29M | $-34M | $-55M | $-47M | $-35M | $-38M | $-42M | $-38M | $-39M | $-46M | $-37M | $-44M | $-48M | |
| CapEx | $256.0K | $89.0K | $304.0K | $62.0K | $168.0K | $246.0K | $44.0K | $59.0K | $331.0K | $30.0K | $195.0K | $933.0K | $2M | $3M | $7M | $10M | |
| Investing Cash Flow | $16M | $17M | $-31M | $3M | $13M | $69M | $54M | $2M | $45M | $22M | $100M | $153M | $32M | $-57M | $25M | $-26M | |
| Stock Issued | · | · | $0 | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $522.0K | $52M | $222.0K | $50M | $183.0K | $1.0K | $437.0K | $0 | $862.0K | $27.0K | $-143.0K | $1M | $-69.0K | $5M | $2M | $3M | |
| Net Change in Cash | $-18M | $31M | $-63M | $25M | $-22M | $15M | $7M | $-33M | $8M | $-20M | $62M | $115M | $-14M | $-89M | $-17M | $-71M | |
| Free Cash Flow | · | $-39M | · | · | · | $-55M | · | · | · | $-42M | · | · | $-48M | · | · | $-58M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1183425.0% | -2213050.0% | · | -248353.3% | -589250.0% | -819528.6% | · | -148544.1% | · | -1852500.0% | -236156.0% | -244092.6% | -96240.0% | -2214566.7% | -104.2% | -12400.7% | |
| Net Margin | -1118875.0% | -1207650.0% | · | -258973.3% | -533550.0% | -745642.9% | · | -131126.5% | · | -2022233.3% | -203412.0% | -236629.6% | -103013.9% | -2341800.0% | -101.6% | -12322.6% | |
| EBITDA Margin | -1183425.0% | -2096450.0% | · | -248353.3% | -589250.0% | -770371.4% | · | -148544.1% | · | -1685033.3% | -236156.0% | -244092.6% | -88506.2% | -2214566.7% | -104.2% | -11643.6% | |
| ROA | -12.8% | -6.2% | · | -7.6% | -8.2% | -9.3% | · | -6.3% | · | -7.7% | -5.7% | -6.9% | -6.9% | -6.5% | -3.2% | -12.7% | |
| ROE | -16.8% | -7.9% | · | -9.0% | -9.9% | -11.1% | · | -7.3% | · | -8.8% | -6.7% | -8.0% | -8.0% | -7.8% | -3.8% | -15.5% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | 7.2 | · | 10.3 | 7.6 | 7.5 | · | 13.4 | · | 16.5 | 16.7 | 17.6 | 20.3 | 12.9 | 13.3 | 15.2 | |
| Quick Ratio | 5.1 | 6.9 | · | 10.0 | 7.5 | 7.3 | · | 13.1 | · | 16.3 | 16.4 | 17.3 | 19.9 | 12.7 | 13.0 | 15.0 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $9.99 | $11.73 | · | $17.06 | $20.16 | $1.14 | · | $2.07 | · | $2.37 | $2.77 | $2.94 | $3.14 | $3.29 | $3.51 | $3.59 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.15 | $0.00 | |
| Cash Flow / Share | · | $-1.76 | · | · | · | $-0.19 | · | · | · | $-0.17 | · | · | $-0.19 | · | · | $-0.20 | |
| Cash / Share | $3.12 | $3.89 | · | $6.40 | $6.66 | $0.41 | · | $0.39 | · | $0.49 | $1.14 | $0.89 | $0.44 | $0.47 | $0.83 | $0.91 | |
| EPS (TTM) | $-16.01 | $-16.98 | · | $-27.48 | $-28.83 | $-29.53 | · | $-25.28 | $-22.00 | $-18.67 | $-0.76 | $-0.84 | $-0.73 | $2.31 | $2.39 | $1.07 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $27.0K | $31.0K | · | $41.0K | $60.0K | $65.0K | · | $63.0K | $54.0K | $68.0K | $49M | $48M | $84M | $39M | $42M | $9M | |
| Net Income TTM | $-248M | $-246M | · | $-326M | $-331M | $-335M | · | $-204M | $-210M | $-228M | $-190M | $-210M | $-182M | $-258M | $-237M | $-263M | |
| Market Cap | $329M | $468M | · | $313M | $131M | $3.18B | · | $7.08B | · | $11.37B | $7.40B | $15.97B | $11.78B | $36.54B | $32.22B | $24.79B | |
| P/E | -0.9 | -1.2 | · | -0.6 | -0.3 | -0.4 | · | -1.1 | -1.3 | -2.4 | -38.7 | -75.7 | -64.7 | 63.5 | 54.6 | 94.4 | |
| P/S | 12175.1 | 15095.5 | · | 7642.3 | 2185.1 | 48880.9 | · | 112399.5 | · | 167202.1 | 152.7 | 329.3 | 139.9 | 934.0 | 769.6 | 2830.3 | |
| P/B | 1.4 | 1.7 | · | 1.0 | 0.4 | 9.4 | · | 13.3 | · | 18.9 | 10.6 | 21.7 | 15.0 | 44.6 | 37.1 | 28.1 | |
| P / Tangible Book | 1.4 | 1.7 | · | 1.0 | 0.4 | 9.4 | · | 13.3 | 13.1 | 18.9 | 10.6 | 21.7 | 15.0 | 44.6 | 37.1 | 28.1 | |
| P / Cash Flow | · | -12.2 | · | · | · | -58.0 | · | · | · | -270.6 | · | · | -254.9 | · | · | -518.0 | |
| Earnings Yield | -113.9% | -84.7% | · | -169.2% | -326.1% | -274.4% | · | -91.6% | -75.9% | -41.9% | -2.6% | -1.3% | -1.6% | 1.6% | 1.8% | 1.1% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $36.0K | $61.0K | $130.0K | $85M | $11M |
| Margen Operativo % | -748344.4% | -588123.0% | -190006.1% | -220.9% | -2016.7% |
| Beneficio neto | $-274M | $-343M | $-235M | $-183M | $-250M |
| EPS Diluido | $-16.06 | $-26.23 | $-18.70 | $-0.74 | $-1.84 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 5.3 | 7.1 | 16.1 | 17.6 | 13.4 |
| Ratio Rápido | 5.0 | 6.9 | 15.8 | 17.3 | 13.2 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-151M | $-163M | $-166M | $-194M | $-192M |
Propietarios institucionales (13F) 95 declarantes · $240.0M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
95
Valor en tenencia
$240.0M
Nuevas posiciones
26
Posiciones cerradas
9
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 26 (+6 vs trimestre anterior) | 9 (+3 vs trimestre anterior) | 29 (+4 vs trimestre anterior) | 19 (+11 vs trimestre anterior) | +67K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| ARCH Venture Management, LLC | $45 525 211 | 3 247 162 | 18,97% | Acciones |
| MWG Caph Ltd | $31 029 810 | 1 008 116 | 12,93% | Acciones |
| VANGUARD GROUP INC | $25 437 516 | 826 430 | 10,60% | Acciones |
| GSK plc | $21 252 859 | 1 512 659 | 8,86% | Acciones |
| MWG Management Ltd. | $16 371 804 | 1 008 116 | 6,82% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $11 054 175 | 786 774 | 4,61% | Acciones |
| Orland Properties Ltd | $10 603 507 | 754 698 | 4,42% | Acciones |
| BlackRock, Inc. | $10 177 005 | 724 342 | 4,24% | Acciones |
| Almitas Capital LLC | $8 168 768 | 581 407 | 3,40% | Acciones |
| Foresite Capital Management V, LLC | $6 693 223 | 476 386 | 2,79% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $5 162 996 | 367 473 | 2,15% | Acciones |
| Opaleye Management Inc. | $4 833 551 | 344 025 | 2,01% | Acciones |
| venBio Partners LLC | $4 744 643 | 337 697 | 1,98% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $4 365 887 | 310 636 | 1,82% | Acciones |
| Alphabet Inc. | $4 120 247 | 293 256 | 1,72% | Acciones |
| STATE STREET CORP | $2 603 774 | 185 322 | 1,08% | Acciones |
| HSG Holding Ltd | $2 139 801 | 152 299 | 0,89% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 829 169 | 130 190 | 0,76% | Acciones |
| NORTHERN TRUST CORP | $1 664 925 | 118 500 | 0,69% | Acciones |
| Qube Research & Technologies Ltd | $1 552 961 | 110 531 | 0,65% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 511 359 | 107 570 | 0,63% | Acciones |
| MARSHALL WACE, LLP | $1 493 516 | 106 300 | 0,62% | Acciones |
| Velan Capital Investment Management LP | $1 475 250 | 105 000 | 0,61% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 307 985 | 93 095 | 0,54% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 291 069 | 91 891 | 0,54% | Acciones |
| MIC Capital Management UK LLP | $1 222 743 | 87 028 | 0,51% | Acciones |
| GOLDMAN SACHS GROUP INC | $1 219 245 | 86 779 | 0,51% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $957 066 | 68 315 | 0,40% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $743 624 | 52 927 | 0,31% | Acciones |
| JANE STREET GROUP, LLC | $646 455 | 46 011 | 0,27% | Acciones |
| Squarepoint Ops LLC | $594 624 | 42 322 | 0,25% | Acciones |
| Ikarian Capital, LLC | $577 188 | 41 081 | 0,24% | Acciones |
| MORGAN STANLEY | $520 553 | 37 050 | 0,22% | Acciones |
| CANADA PENSION PLAN INVESTMENT BOARD | $413 225 | 29 411 | 0,17% | Acciones |
| Point72 Asset Management, L.P. | $366 424 | 26 080 | 0,15% | Acciones |
| UBS Group AG | $365 048 | 25 982 | 0,15% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $363 895 | 25 900 | 0,15% | Opción de compra |
| Bank of New York Mellon Corp | $346 656 | 24 673 | 0,14% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $344 787 | 24 540 | 0,14% | Acciones |
| Jump Financial, LLC | $308 482 | 21 956 | 0,13% | Acciones |
| Clearstead Advisors, LLC | $280 410 | 19 958 | 0,12% | Acciones |
| EntryPoint Capital, LLC | $272 710 | 19 410 | 0,11% | Acciones |
| CITADEL ADVISORS LLC | $262 665 | 18 695 | 0,11% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $252 900 | 18 000 | 0,11% | Acciones |
| CITADEL ADVISORS LLC | $251 495 | 17 900 | 0,10% | Opción de venta |
| Susquehanna Portfolio Strategies, LLC | $251 144 | 17 875 | 0,10% | Acciones |
| CITADEL ADVISORS LLC | $238 850 | 17 000 | 0,10% | Opción de compra |
| Allspring Global Investments Holdings, LLC | $226 837 | 16 145 | 0,09% | Acciones |
| RHUMBLINE ADVISERS | $217 234 | 15 462 | 0,09% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $199 510 | 14 200 | 0,08% | Opción de venta |
Informantes de la empresa 25 insiders · 14 directivos · 11 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Lynn Seely | President and CEO | 21 de agosto de 2026 S | 63 899 | 0 | 6 | $-353 079 |
| Elizabeth Homans | Chief Executive Officer | 16 de marzo de 2022 A | · | 0 | 0 | $0 |
| Charles W. Newton | Chief Financial Officer | 21 de agosto de 2025 S | 15 306 | 0 | 0 | $0 |
| Stephen J. Hill | Chief Operating Officer | 21 de agosto de 2026 S | 16 816 | 0 | 6 | $-51 290 |
| Jarrad Mattieu Aguirre | Chief Medical Officer | 10 de septiembre de 2026 A | · | 0 | 0 | $0 |
| David Shook | Chief Medical Officer | 10 de septiembre de 2026 S | 20 423 | 0 | 2 | $-31 339 |
| Gary K. Lee | Chief Scientific Officer | 21 de agosto de 2026 S | 16 220 | 0 | 6 | $-71 695 |
| Veronica Sanchez Bulis | VP, Corporate Controller | 10 de agosto de 2026 S | 14 799 | 0 | 6 | $-96 909 |
| Smital Shah | Chief Fin. and Bus. Officer | 9 de marzo de 2026 A | · | 0 | 0 | $0 |
| Mark A Meltz | General Counsel | 10 de febrero de 2026 A | · | 0 | 0 | $0 |
| Matthew Lang | Chief Business Officer | 10 de febrero de 2025 A | 162 500 | 0 | 0 | $0 |
| Tina M. Albertson | Chief Medical Officer | 24 de febrero de 2023 A | · | 0 | 0 | $0 |
| Rahsaan Thompson | Chief Legal Officer | 24 de febrero de 2023 A | · | 0 | 0 | $0 |
| Heather D Turner | Chief General Counsel | 16 de marzo de 2022 A | · | 0 | 0 | $0 |
| Mark Bachleda | Consejero | 10 de junio de 2026 A | · | 0 | 0 | $0 |
| Elizabeth G Nabel | Consejero | 10 de junio de 2026 A | · | 0 | 0 | $0 |
| Richard Klausner | Consejero | 10 de junio de 2026 A | 843 365 | 0 | 0 | $0 |
| Sumant Ramachandra | Consejero | 10 de junio de 2026 A | 200 000 | 0 | 0 | $0 |
| Cathy Friedman | Consejero | 10 de junio de 2026 A | 236 370 | 0 | 0 | $0 |
| Otis W Brawley | Consejero | 10 de junio de 2026 A | 35 640 | 0 | 0 | $0 |
| William Jl Rieflin | Consejero | 10 de junio de 2026 A | · | 0 | 0 | $0 |
| Hans Edgar Bishop | Consejero | 14 de junio de 2024 A | 4 685 614 | 0 | 0 | $0 |
| Robert Nelsen | Consejero | 14 de junio de 2024 A | 18 206 358 | 0 | 0 | $0 |
| Innovative Cellular Therapeutics Holdings Ltd | Propietario del 10% | 27 de julio de 2026 J | 2 818 980 | 0 | 2 | $-274 |
| GSK plc | · | 21 de junio de 2021 C | 30 253 189 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 16 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,03% | 32 319 SH | 11 de septiembre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,01% | 1 674 SH | 2 de octubre de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 8 183 SH | 19 de agosto de 2026 | Diario |
| IBB · iShares Trust | 0,01% | 57 662 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,00% | 4 474 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 222 823 SH | 11 de septiembre de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 8 835 SH | 2 de octubre de 2026 | Diario |
| DCOR · Dimensional ETF Trust | 0,00% | 1 961 NS | 31 de julio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 1 736 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 163 755 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 604 461 SH | 19 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 54 398 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1 151 SH | 19 de agosto de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,00% | 409 NS | 31 de julio de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,00% | 28 159 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 89 130 SH | 11 de septiembre de 2026 | Diario |
LYEL Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 14 analistas
COMPRA
Objetivo mediano
$41.50
+348,2%
4 28,6%
Compra fuerte
8 57,1%
Compra
1 7,1%
Mantener
1 7,1%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
8 analistas · 2026-10-02Objetivo medio $37.88 +309,0%
← Por Debajo de Todos los Objetivos
Precio Actual $9.26
Mín$12.00
Media$37.88
Máx$49.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | · |
| CAMP | $318M | -2.3 | 436.5% | -2298.5% | -183.4% | · |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | · |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | · |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | · |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | · |
| KROS | $398M | 8.9 | · | 35.7% | 17.2% | · |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026